TY  - GEN
AU  - Rubio,Marie Thérèse
AU  - D'Aveni-Piney,Maud
AU  - Labopin,Myriam
AU  - Hamladji,Rose-Marie
AU  - Sanz,Miguel A
AU  - Blaise,Didier
AU  - Ozdogu,Hakan
AU  - Daguindeau,Etienne
AU  - Richard,Carlos
AU  - Santarone,Stella
AU  - Irrera,Giuseppe
AU  - Yakoub-Agha,Ibrahim
AU  - Yeshurun,Moshe
AU  - Diez-Martin,Jose L
AU  - Mohty,Mohamad
AU  - Savani,Bipin N
AU  - Nagler,Arnon
TI  - Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party
SN  - 1756-8722
PY  - 2017///1128
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antilymphocyte Serum
KW  - therapeutic use
KW  - Busulfan
KW  - Female
KW  - Graft vs Host Disease
KW  - prevention & control
KW  - HLA Antigens
KW  - Hematopoietic Stem Cell Transplantation
KW  - methods
KW  - Histocompatibility
KW  - immunology
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - therapy
KW  - Leukocyte Reduction Procedures
KW  - Lymphocyte Depletion
KW  - Male
KW  - Middle Aged
KW  - Myeloablative Agonists
KW  - Retrospective Studies
KW  - T-Lymphocytes
KW  - Transplantation Conditioning
KW  - Treatment Outcome
KW  - Vidarabine
KW  - analogs & derivatives
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1186/s13045-016-0389-4
ER  -